Cinical Trial to Explore the Efficacy of Statin/Choline Fenofibrate Combination Therapy vs Statin Monotherapy in Patients With Inadequately Controlled TG Despite Receiving Statin Monotherapy

• Status: Unknown status
• Trial end date: 2020-03-31
• Target enrollment: 0
• Participant gender: All

Summary

A Multi-center, Randomized, Double-blind, Parallel Phase Ⅳ Study to Explore the Efficacy of Statin/Choline Fenofibrate Combination Therapy vs Statin Monotherapy in Patients With Inadequately Controlled TG Despite Receiving Statin Monotherapy

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Daewon Pharmaceutical Co., Ltd.
• Treatments: Choline; Fenofibrate; Hydroxymethylglutaryl-CoA Reductase Inhibitors

Criteria

Inclusion Criteria:

• both male and female who are over 19-year-old

• 200mg/dl≤TG<500mg/dl

• Desired value of LDL-c

1. very high risk < 70

2. high risk < 100

3. moderate risk <130

4. low risk < 160

Exclusion Criteria:

• patient who is going to have an operation during this study

• patient who has allergy or hypersensitivity of fenofibrate

• patient who has abnormal ECG